TRIAL ORGANIZATION
For general information contact us on mrclean@erasmusmc.nl
Study executive committee:
- Manon Kappelhof, junior researcher, AMC, Amsterdam
- Josje Brouwer, junior researcher, AMC, Amsterdam
- Wouter Hinsenveld, junior researcher, MUMC, Maastricht
- Sanne den Hartog, junior researcher, Erasmus MC, Rotterdam
- Kars Compagne, junior researcher, Erasmus MC, Rotterdam
- Robert-Jan Goldhoorn, junior researcher, MUMC, Maastricht
- Charles Majoie, neuro-radiologist, AMC, Amsterdam
- Aad van der Lugt, neuro-radiologist, Erasmus Medical Center, Rotterdam
- Robert van Oostenbrugge, neurologist, Medical Center Maastricht, Maastricht
- Wim van Zwam, neuro-radiologist, Medical Center Maastricht, Maastricht
- Jan Albert Vos, neuro-radiologist, St. Antonius Hospital, Nieuwegein
- Jelis Boiten, neurologist, Medical Center Haaglanden, The Hague
- Yvo Roos, neurologist, AMC, Amsterdam
- Diederik Dippel, neurologist, Erasmus Medical Center, Rotterdam
The executive committee and the local principal investigators form the study steering committee
Study committees:
Imaging committee
blind, independent assessment of CTA, CT perfusion and DSA scans.
chair: Charles Majoie, neuroradiologist, AMC
Serious adverse event adjudication committee
blind, independent assessment of reports of serious adverse events, submitted by investigators.
Chair: Robert van Oostenbrugge, neurologist, MUMC+.
Our statistical advisors and trial statisticians are
Prof Ewout Steyerberg, methodologist, dept of Public Health, Erasmus MC Rotterdam
Hester Lingsma, methodologist, dept of Public Health, Erasmus MC Rotterdam